Research Paper Volume 16, Issue 1 pp 431—444
TBC1D1 represses glioma progression by altering the integrity of the cytoskeleton
Figure 2. Relationship between TBC1D1 expression and clinical features. (A–E) Relationship of TBC1D1 expression to age, IDH mutation status, 1p19q codeletion status, grade, histology in CGGA databases. (F–J) Relationship between TBC1D1 expression and age, IDH mutation status, 1p19q co-deletion status, grade, and histology in the TCGA database.